Last reviewed · How we verify

NCT03967106: MSIPC-2

RIPC on Activity, Fatigue and Gait in MS

Completed NA Last updated 5 January 2024
What this trial tests

NA trial testing Ischaemic Preconditioning in Multiple Sclerosis in 92 participants. Completed in 31 March 2023.

Timeline
19 August 2019
Primary endpoint
31 March 2023
31 March 2023

Quick facts

Lead sponsorSheffield Teaching Hospitals NHS Foundation Trust
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment92
Start date19 August 2019
Primary completion31 March 2023
Estimated completion31 March 2023
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates whether Remote Ischaemic Preconditioning (RIPC) can improve activity, gait and fatigue in people with Multiple Sclerosis. Half the participants will receive RIPC, the other half will receive a sham treatment.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Mobility recorded by wearable devices and gold standards: the Mobilise-D procedure for data standardization.
    Palmerini L, Reggi L, Bonci T, Del Din S, et al · · 2023 · cited 25× · PMID 36658136 · DOI 10.1038/s41597-023-01930-9
  2. Remote ischaemic conditioning for neurological disorders-a systematic review and narrative synthesis.
    Alhashimi A, Kamarova M, Baig SS, Nair KPS, et al · · 2024 · cited 5× · PMID 39702489 · DOI 10.1186/s13643-024-02725-8
  3. Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.
    Binshalan T, Buckley E, Nair S, Mcneill A. · · 2024 · cited 1× · PMID 38322083 · DOI 10.7759/cureus.51811
  4. Abstracts of the BSPRM Annual Scientific Conference 2024
    · 2025
  5. Remote Ischaemic Conditioning for Neurological Disorders – A Systematic Review and Narrative Synthesis
    Alhashimi A, Kamarova M, B S, Nair KS, et al · · 2024 · DOI 10.21203/rs.3.rs-3974093/v1

Verify or expand the search:

Other trials of Ischaemic Preconditioning

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Sheffield Teaching Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03967106.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing